Diabeteszentrum, Bad Lauterberg, 25.01.2003
While, in theory, combining L-Carnitine and L-Theanine could offer complementary benefitsone enhancing energy and the other promoting relaxationthere are currently no scientific studies that directly validate this hypothesis
PLoS ONE 11(10):e0163907 Bjornstad P, Hughan KS, Kelsey MM, Shah A, Lynch JL, Nehus E et al (2019) 123-OR: effect of surgical vs medical therapy on diabetic kidney disease (DKD) in severely obese adolescents with type 2 diabetes (T2D)
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
It is an investigational triple-receptor agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors pathways involved in glucose regulation, energy balance, and metabolic homeostasis